Organon & Co | Zahlungsmittel Und Äquivalente



Cash And Equivalent Veränderung Datum
Adcock Ingram Holdings ZAR 79.14M 10.28M 2024-12
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Celltrion KRW 972.66B 68.24B 2024-09
Cspc Pharmaceutical 8.37B 3.64B 2024-06
Dianthus Therapeutics USD 22.79M 10.88M 2024-12
Gilead Sciences USD 7.93B 2.06B 2025-03
Glaxosmithkline GBP 3.87B 678M 2024-12
Kangmei Pharma CNY 773.51M 28.83M 2024-09
Knight Therapeutics CAD 5.81M 3.59M 2024-09
Laboratorios Farma EUR 27.19M 17.39M 2024-12
Malin Corporation EUR 35.7M 6.4M 2024-06
Medical Developments International AUD 9.74M 5.96M 2024-06
Merck USD 8.63B 4.61B 2025-03
Neuren Pharmaceuticals AUD 3.15M 582K 2024-12
Novartis USD 11.46B 2.15B 2024-12
Organon & Co USD 547M 128M 2025-03
Pharma Mar EUR 60.29M 2.95M 2025-03
Qiagen NV USD 663.56M 309.42M 2024-12
Sartorius EUR 839.5M 26.1M 2025-03
Sino Biopharmaceutical CNY 8.55B 902.41M 2024-06
Tilray USD 189.7M 15.49M 2024-11



Organon & Co Zahlungsmittel Und Äquivalente - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.